Publication #: 1103 Type: Poster Presentation Title: Two Pre-clinical Short Interfering RNA Molecules Targeting Human HSD17beta13 for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving endoscopic improvement and 30.2% achieving clinical remission at the highest dose ...
Milestone Pharmaceuticals Inc. is advancing CARDAMYST, a self-administered nasal spray for PSVT. Click here to read why MIST ...
Stage Two dewatering advancing on schedule; approximately 20% complete Start-up of Africa’s largest copper smelter to ...
Ethan Evans on MSN
You Are The Product: How to Continuously Develop Yourself and Your Organization for Improved Performance
Your guide to grow fast, avoid mistakes, and make optimal career moves. We’ve got exciting upcoming community events exclusively for paid newsletter subscribers. These are designed to help you connect ...
PARK CITY, Utah — Park City READS will welcome nationally recognized literacy expert Nancy Redding, M.Ed., for two events in ...
Introduction Wednesday, Sept. 24 to Friday, Sept. 26, the College of William and Mary’s board of visitors met in Blow ...
Explore India on MSN
India Rising a Journey of Growth and Development
Discover how India is rising as a global force through growth, innovation, and development. This video explores India’s ...
Reports 3.6% Increase in NAV and 0.4% Increase in NAV Per Share from Previous Quarter Quarterly ROE of 13.8% Generates LTM ROE of 9.1% and Beats ...
Exor is the Amsterdam-listed holding company of the Agnelli family, who own 55.2% of the economic interest, but control over ...
Although these deaths had a variety of causes, malnutrition is a well documented problem among Indigenous people in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback